Volume 29, Number 6—June 2023
Dispatch
SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
Table
Sample | Days between sampling | Titer |
% Decrease per day |
|||||
---|---|---|---|---|---|---|---|---|
B.1 | Alpha | Delta | B.1 | Alpha | Delta | |||
Cat F | 12 | 490 | 257 | 601 | 5.90 | 0.90 | 4.10 | |
146 |
229 |
303 |
||||||
Cat G | 175 | 586 | 677 | 243 | 0.40 | 0.40 | 0.40 | |
134 |
170 |
58 |
||||||
Cat H | 94 | 687 | 825 | 2,165 | 0.30 | 0.20 | 0.70 | |
474 |
678 |
685 |
||||||
Cat J | 175 | 627 | 719 | 247 | 0.30 | 0.40 | 0.40 | |
318 |
241 |
79 |
||||||
Cat L | 23 | 109 | 102 | 468 | −7.20 | 1.40 | 1.60 | |
289 | 70 | 301 |
*We used 2 samples from each of 5 animals, taken >12 d apart. The earlier sample was used in the overall analysis; however, newer samples were also tested. Values related to each variant are shown for each sample, with the earlier sample above and later below. Titers are color-coded by size (stronger titers and greater decreases are shown with darker shading). B.1 indicates ancestral/wild-type virus.
Page created: April 13, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.